Citigroup
CRCA

Citigroup’s ProShares Ultra CRCL CRCA Stock Holding History

Citigroup’s Portfolio CRCA Stock Details CRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$87.3K Buy
+6,814
New +$263K ﹤0.01% 4760

Other funds holding CRCA

Optiver Holding
Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $1.54B AUM 30.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $80B AUM 26.12% 1-Year Est. Return

Citigroup's CRCA Position: Q2 2026 in Review

Citigroup opened a new position in ProShares Ultra CRCL (CRCA) in Q2 2026: 6,814 shares worth $87.3K. The stake represents ﹤0.01% of the portfolio and ranks #4760 among its holdings.

7 funds tracked by Wall St. Rank hold CRCA as of Q2 2026.

  • Citigroup held 6,814 shares of ProShares Ultra CRCL worth $87.3K as of Q2 2026.
  • ProShares Ultra CRCL was a new Citigroup position in Q2 2026.
  • ProShares Ultra CRCL made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #4760 holding.
  • 7 funds tracked by Wall St. Rank held ProShares Ultra CRCL as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.